Trials / Unknown
UnknownNCT03272152
Comprehensive DNA Methylation Profiling in Crohn's Disease
Comprehensive DNA Methylation Profiling of Inflammatory and Non-Inflammatory Mucosa in Crohn's Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (estimated)
- Sponsor
- Jinling Hospital, China · Academic / Other
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Previous studies have indicated that abnormal DNA methylation frequently occurs in the mucosa in Crohn's disease. Comprehensive DNA methylation profiling of the inflamed and non-inflamed ileal mucosa of patients with Crohn's disease was performed. Genome-wide DNA methylation was determined using the Illumina HumanMethylation 850k BeadChip.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Genome-wide DNA methylation | Genome-wide DNA methylation was determined using the Infinium Human Methylation 850K BeadChip. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-09-30
- Completion
- 2017-09-30
- First posted
- 2017-09-05
- Last updated
- 2017-09-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03272152. Inclusion in this directory is not an endorsement.